2015 INS Annual Meeting
October 15-16
Chicago, IL, USA

Meeting Program

Thursday, October 15

Northwestern University Hughes Auditorium
303 E Superior Street, Chicago, IL

Welcome

5:00pm
Barbara J. Sahakian, INS President & University of Cambridge

Is Professional Football Safe? Could We Make It Safer? Perspectives from Neuroscience, Law, and Ethics

Public Program
5:00 - 6:30 pm

Moderator: Nita Farahany, Duke University & INS Board Member
Alvaro Pascual-Leone, Harvard Medical School
I. Glenn Cohen, Harvard Law School
Damien Richardson, Banner University Medical Center and former NFL Player

Meet and Greet

6:30 - 7:15 pm

RSVPFree admission; RSVP before October 12

Affinity Groups Dinner

7:30 pm
The Affinity Groups dinner will be held at a nearby restaurant following the Public Program reception. Reservation details will be available at the Public Program reception and will also be distributed by email next week to participants who have already confirmed their attendance.

 

Friday attendees must use the Art Institute's entrance at:
230 South Columbus Drive, Chicago, IL

All panels and presentations, breakfast, lunch, and the evening reception will be held in the Chicago Stock Exchange Trading Room at the Art Institute of Chicago.

Posters will remain displayed all day. Poster presenters must visit the INS registration table between 8:00 and 8:30 am on Friday morning. The poster reception will begin at 5:30 pm.

Register to attend the 2015 INS Annual Meeting sessions and networking activities on Friday, October 16.

STANDARD RATES APPLY THROUGH OCTOBER 13

Registration
Friday, October 16

Art Institute of Chicago, Chicago Stock Exchange Trading Room
230 S Columbus Drive, Chicago, IL

Continental Breakfast
Chicago Stock Exchange Trading Room
8:00 - 9:00 am

Welcome

9:00 - 9:05 am
Introduction by Barbara J. Sahakian, INS President & University of Cambridge

Implementing Gray Matters: Perspectives on Bioethics Commission Recommendations

9:05 - 10:30 am
Moderator: Dan Sulmasy, Presidential Commission for the Study of Bioethical Issues
William Casebeer, Lockheed Martin Advanced Technology Laboratories
Debra Mathews, Johns Hopkins University & INS Board Member
Hannah Maslen, University of Oxford

Break

10:30 - 11:00 am

Global Mental Health

11:00 am - 12:30 pm
Moderator: John Pickard, University of Cambridge
Hans-Ulrich Wittchen, European College of Neuropsychopharmacology
Dana March, Columbia University Medical Center
Judy Illes, University of British Columbia & INS President-Elect

Lunch & Open Business Meeting

12:30 - 2:00 pm

Abstract Oral Presentations

2:00 - 2:55 pm
Introductions by Jens Clausen, University of Tubingen & INS Program Committee
Seven select authors will speak for five minutes each about their research, as designated in the list of accepted abstracts.

Student Essay Contest

2:55 - 3:00 pm
Introductions by Matthew Baum, Harvard Medical School & INS Student Representative
Award sponsored by Dr. Michael Patterson, Kopf Carrier
2015 winning essays by Joseph Wszalek, University of Wisconsin-Madison, and Jennifer Lee, McGill University

Mental Health Disorders in Prison: Neuroethical & Societal Issues

3:00 - 4:30 pm
Moderator: Alan Leshner, American Association for the Advancement of Science Emeritus
James Blair, National Institute of Mental Health
James Giordano, Georgetown University
Hank Greely, Stanford University & INS Board Member

Register to attend the 2015 INS Annual Meeting sessions and networking activities on Friday, October 16.

STANDARD RATES APPLY THROUGH OCTOBER 13

Registration

Break

4:30 - 5:00 pm

Award Presentations, Announcements, and Introductions

5:00 - 5:30 pm

Poster Session and Reception

Chicago Stock Exchange Trading Room
5:30 - 6:45 pm
Posters will be displayed in the Chicago Stock Exchange Trading Room all day.


Sessions & Speakers

Friday, October 16

Art Institute of Chicago, Chicago Stock Exchange Trading Room
230 S Columbus Drive, Chicago, IL

Implementing Gray Matters: Perspectives on Bioethics Commission Recommendations

The Presidential Commission for the Study of Bioethical Issues (Bioethics Commission) recently released a two-volume report entitled Gray Matters, which included recommendations for advancing neuroscience research through ethics integration and analysis of potential ethical and societal implications of research results and their applications. This panel will discuss various perspectives on the implementation of the Bioethics Commission's recommendations. Moderator Daniel Sulmasy will open the panel with a discussion about the Gray Matters report and the Bioethics Commission’s recommendations. Hannah Malsen will consider practical points related to implementation of the recommendations; William Casebeer will examine challenges to implementation and how they might be addressed; and Debra Mathews will discuss ethics integration in neuroscience research.

Dan Sulmasy
Dan Sulmasy

Presidential Commission for the Study of Bioethical Issues
Dr. Sulmasy is the Kilbride-Clinton Professor of Medicine and Ethics in the Department of Medicine and Divinity School at the University of Chicago, where he serves as Associate Director of the MacLean Center for Clinical Medical Ethics and as Director of the Program on Medicine and Religion. He has previously held faculty positions at New York Medical College and at Georgetown University. He received his AB and MD degrees from Cornell University, completed his residency, chief residency, and post-doctoral fellowship in General Internal Medicine at the Johns Hopkins Hospital, and holds a PhD in philosophy from Georgetown University. He has served on numerous governmental advisory committees, and was appointed to the Presidential Commission for the Study of Bioethical Issues by President Obama in 2010. His research interests encompass both theoretical and empirical investigations of the ethics of end-of-life decision-making, ethics education, and spirituality in medicine. He is the author or editor of six books—The Healer’s Calling (1997), Methods in Medical Ethics (1st ed., 2001; 2nd ed., 2010), The Rebirth of the Clinic (2006), A Balm for Gilead (2006), Safe Passage: A Global Spiritual Sourcebook for Care at the End of Life (2014), and Francis the Leper: Faith, Medicine, Theology, and Science (2014). He also serves as editor-in-chief of the journal, Theoretical Medicine and Bioethics.

William Casebeer
William Casebeer

Lockheed Martin Advanced Technology Laboratories
Bill Casebeer is a Research Area Manager in human systems optimization for Lockheed Martin’s Advanced Technology Laboratories, where he leads science and technology development programs to improve human performance. Bill served as a Program Manager at the Defense Advanced Research Projects Agency from 2010-14 in the Defense Sciences Office and in the Biological Technologies Office, where he established DARPA’s neuroethics program. He retired from active duty as a US Air Force Lieutenant Colonel and intelligence analyst in August 2011, where he earned multiple Distinguished Meritorious Service medals. He holds a Bachelor of Science in political science from the US Air Force Academy, a Master of Arts in national security studies from the Naval Postgraduate School, a Master of Arts in philosophy from the University of Arizona and a joint PhD in cognitive science and philosophy from the University of California at San Diego. Formerly an Associate Professor of Philosophy at the Air Force Academy, Casebeer was a fellow at the Carr Center for Human Rights Policy at Harvard’s Kennedy School of Government 2005-2006. He was a term member of the Council on Foreign Relations and is an experienced Middle East analyst with multiple deployments to the region. Bill is author of Natural Ethical Facts: Evolution, Connectionism, and Moral Cognition (MIT Press), co-author of Warlords Rising: Confronting Violent Non-State Actors (Lexington Books), and has published on topics from the morality of torture interrogation to the rhetoric of evil in international relations in venues such as Nature Reviews Neuroscience, Biology and Philosophy, and International Studies. His research interests include the intersections of cognitive science and national security policy, neuroethics, political violence, philosophy of mind, and human performance.

Debra Mathews
Debra Mathews

Johns Hopkins University
INS Board Member

Debra JH Mathews, PhD, MA, is the Assistant Director for Science Programs at the Johns Hopkins Berman Institute of Bioethics, an Associate Professor in the Department of Pediatrics, and Affiliate Faculty in the McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins School of Medicine. Dr. Mathews earned her PhD in genetics from Case Western Reserve University. Concurrent with her PhD, she earned a Master’s degree in bioethics, also from Case. She completed a Post-Doctoral Fellowship in genetics at Johns Hopkins and the Greenwall Fellowship in Bioethics and Health Policy, at Johns Hopkins and Georgetown Universities. As a Greenwall Fellow, she worked at the Genetics and Public Policy Center, in Washington, DC, and the US Department of Health and Human Services. Dr. Mathews served part time on the staff of the Presidential Commission for the Study of Bioethical Issues, as a Senior Policy and Research Analyst and a staff lead on the Commission’s genomics report. Dr. Mathews's research interests focus on the intersection of emerging biotechnologies, ethics and public policy, particularly in the areas of genetics, stem cell science, neuroscience and synthetic biology. She also has a focus on ethics, policy and communication training for bench science students and researchers.

Hannah Maslen
Hannah Maslen

University of Oxford
Hannah is a Research Fellow in Ethics at the Oxford Uehiro Centre for Practical Ethics. She has a background in philosophy, psychology and law, and currently works on the ethical, legal and social implications of various brain intervention and interface technologies, under the project title Mind and Machine. Amongst her recent publications is a series of articles on the ethics and regulation of various brain stimulation devices, examined within both medical and commercial contexts. Hannah is currently working with the European Commission's New and Emerging Technologies Working Group group to develop new paradigms for the regulatory assessment of devices sold for cognitive enhancement. Her broader research encompasses other neuroethical topics, such as the development and use of virtual reality and immersive technologies, as well as the use of brain-computer interface technology by the military. Beyond neuroethics, Hannah also works on the philosophy of moral emotions and their relevance in the criminal justice system. She has published a book on remorse and retributive punishment: Remorse, Penal Theory and Sentencing, Hart Publishing, Oxford. More information about Hannah and her research can be found at her personal website.


Global Mental Health

Neuropsychiatric disorders, such as schizophrenia, depression and dementia, constitute 13% of the global burden of disease, surpassing both cardiovascular disease and cancer. Epidemiological studies on mental health disorders throughout the world have shown that each year, up to a third of people suffer from a mental health disorder. Despite the fact that neuropsychiatric disorders are common, there is still considerable stigma, as well as lack of funding for research into the aetiology and treatment of these disorders. In this panel, we will discuss important European and global initiatives to document the size and burden of mental health disorders, and recommendations for improving mental health. This panel will also reflect on the ethical imperatives for improving mental health worldwide.

John Pickard
John Pickard

University of Cambridge
John Pickard is professor emeritus of neurosurgery in the Department of Clinical Neurosciences of University of Cambridge. He is the honorary director of the National Institute for Health Research's Healthcare Technology Cooperative (HTC) for brain injury. His research focuses on advancing the care of patients with acute brain injury, hydrocephalus and prolonged disorders of consciousness through functional brain imaging, studies of pathophysiology and new treatments; as well as focusing on health, economic and ethical aspects. His discoveries have included the definition of how early insults to the brain in both childhood and later life may lead to late changes and cognitive outcome, new ways of detecting when the blood supply to critical areas of the brain become at risk, which treatments may be helpful (Nimodipine) and which counterproductive, the detection of awareness in the "vegetative" state (fMR), identification of which parts of the brain are affected in normal pressure hydrocephalus, and novel treatment for pseudotumor cerebri. Pickard is an emeritus professorial fellow at St Catharine's College, Cambridge, having retired as a professorial fellow and director of studies in medical sciences. He served as president of the Society of British Neurological Surgeons from 2006 to 2008.

Hans-Ulrich Wittchen
Hans-Ulrich Wittchen

European College of Neuropsychopharmacology
Since 2000, Dr. Wittchen is director of the Institute of Clinical Psychology and Psychotherapy at the Technische Universität Dresden, including the Center of Clinical Epidemiology and Longitudinal Studies (CELOS) and the Clinical Outpatient and Day-Care Centre for Psychotherapy (IAP-TU Dresden GmbH). Wittchen is and has been principal investigator and co-investigator of many national and international research programs and large-scale epidemiological studies. His work encompasses a wide range of etiological-pathogenetic, family-genetic, experimental, clinical and epidemiological studies with a focus on prospective-longitudinal studies in addiction, anxiety, mood and somatic disorders. He has been instrumental in developing sophisticated concepts of comorbidity, the derivation of symptom progression models, the derivation of new behavioral treatment methods and translational research. More recently, his work has also extended into behavioral medicine by examining the interrelationship between mental disorders and a wide range of somatic and neurologic conditions, including cardiac diseases, diabetes, Parkinson's disease and Multiple Sclerosis.

Dana March
Dana March

Columbia University Medical Center
Dana March, is an Assistant Professor in the Department of Epidemiology at Columbia’s Mailman School of Public Health. Her research addresses the ways in which our social lives and where we live shape population health and how we respond to interventions. She has particular interests in urbanization and the social fault lines of health, like race and class, with projects in the United States, the United Kingdom, and China. She also directs the Communicating Health and Epidemiology Fellowship of the2x2project, which trains future public health science communicators. March received her Ph.D. in epidemiology with distinction from Columbia University in 2010. Her academic publications have addressed approaches to conceptualizing the social environment for scientific research, the intersection of physical and mental health, priorities for global mental health research, and the intellectual history of epidemiology. March has written for Newsweek and USA Today, and has been an expert commentator for Al Jazeera America. Her work has been featured in Scientific American. She is a 2014-15 Op-Ed Project Public Voices Fellow at Columbia University Medical Center.

Judy Illes
Judy Illes

University of British Columbia
INS President-Elect

Dr. Judy Illes is Professor of Neurology and Canada Research Chair in Neuroethics at the University of British Columbia. She is Director of the National Core for Neuroethics at UBC, and faculty in the Brain Research Centre and the Vancouver Coastal Health Research Institute. Dr. Illes is a co-Founder and Member of the Governing Board of the International Neuroethics Society. As a pioneer and eminent scholar in the field of Neuroethics, she has made ground-making contributions to ethical, social, and policy challenges at the intersection of biomedical ethics and neuroscience, including advances in stem cells, neuroimaging, neuroscience and the law, and the commercialization of health care.


Mental Health Disorders in Prison: Neuroethical & Societal Issues

This session will consider vulnerabilities to mental health problems of those in prison, and whether there are inequalities in access to psychiatrists, psychologists and other mental health professionals for diagnosis and treatment. This panel will reflect on what steps society should be taking, in terms of: the ethical and human rights issues of inequality of access to treatment for mental health disorders in the prison population; improving cognition, functionality and wellbeing for those with mental health problems while incarcerated and when released; and the role that society should take in providing opportunities for participation and flourishing in society of this vulnerable group. For additional information, read Barbara Sahakian's blog post about this session on the Dana Foundation Blog. 

Alan Leshner
Alan Leshner

American Association for the Advancement of Science Emeritus
Dr. Leshner is Chief Executive Officer, Emeritus, of the American Association for the Advancement of Science (AAAS) and Former Executive Publisher of the journal Science. Before this position, Dr. Leshner was Director of the National Institute on Drug Abuse at the National Institutes of Health. He also served as Deputy Director and Acting Director of the National Institute of Mental Health, and in several roles at the National Science Foundation. Before joining the government, Dr. Leshner was Professor of Psychology at Bucknell University. Dr. Leshner is an elected fellow of AAAS, the American Academy of Arts and Sciences, the National Academy of Public Administration, and many other professional societies. He is a member and served on the governing Council of the Institute of Medicine of the National Academies of Science. He was appointed by President Bush to the National Science Board in 2004, and then reappointed by President Obama in 2011. Dr. Leshner received Ph.D. and M.S. degrees in physiological psychology from Rutgers University and an A.B. in psychology from Franklin and Marshall College. He has been awarded seven honorary Doctor of Science degrees.

James Blair
James Blair

National Institute of Mental Health
James Blair is Chief of the Unit on Affective Cognitive Neuroscience at NIMH. Dr. Blair received a doctoral degree in Psychology from University College London in 1993 under the supervision of Professor John Morton. Following graduation he was awarded a Wellcome Trust Mental Health Research Fellowship that he held at the Medical Research Council Cognitive Development Unit for three years. Subsequently, he moved to the Institute of Cognitive Neuroscience, University College London. There, with Uta Frith, he helped form and co-lead the Developmental Disorders group, and was ultimately appointed Senior Lecturer. He Joined the NIMH Intramural Research Program in 2002. Dr. Blair's primary research interest involves understanding the neuro-cognitive systems mediating affect in humans and how these become dysfunctional in mood and anxiety disorders. His primary clinical focus is in understanding the dysfunction of affect-related systems in youth with specific forms of conduct disorder. His research approach includes techniques employed in cognitive neuroscience (both neuropsychology and functional imaging), psychopharmacology and, more recently, molecular genetics.

Scheduled speaker Laurie R. Garduque, MacArthur Foundation, is unable to attend the meeting and James Giordano will be presenting in her place.

Jim Giordano
James Giordano

Georgetown University
James Giordano PhD, MPhil is Professor in the Departments of Neurology and Biochemistry; Chief of the Neuroethics Studies Program of the Pellegrino Center for Clinical Bioethics, and Co-director of the O’Neill-Pellegrino Program for Brain Science and Global Health Law and Policy at Georgetown University Medical Center, Washington, DC, USA. As well, he is the Clark Faculty Fellow in Neuroethics at the Ludwig-Maximilians University, Munich, Germany, where he previously was JW Fulbright Visiting Professor. Prof. Giordano is Senior Science Advisory Fellow to the Strategic Multilayer Analysis Group of the Joint Staff at The Pentagon, and serves an appointed member of the Neuroethics, Legal and Social Issues (NELSI) Advisory Panel of the Defense Advanced Research Projects’ Agency (DARPA), engaging neuroethical aspects of advanced brain stimulation programs. The author of over 200 publications in neuroscience and ethics, his most recent books are Neurotechnology in National Security and Defense: Practical Considerations, Neuroethical Concerns (CRC Press); Neurotechnology: Premises, Potential and Problems (CRC Press); Scientific and Philosophical Perspectives in Neuroethics (with Bert Gordijn; Cambridge), and Pain Medicine: Philosophy, Ethics and Policy (with Mark Boswell; Linton-Atlantic). He is the Editor-in-Chief of the BioMed Central journal Philosophy, Ethics and Humanities in Medicine; Associate Editor of Cambridge Quarterly of Healthcare Ethics’ Neuroethics Now; Executive Co-editor-in-Chief of the book series Advances in Neurotechnology: Ethical, Legal and Social Issues (CRC-Informa), and Executive Co-editor-in-Chief (with John R. Shook) of Brill Press’s Brain Science, Philosophy and Ethics book series. He was awarded an MPhil (philosophy of psychology) and PhD (with distinction) in biopsychology from the City University of New York, NY, was NIEHS post-doctoral fellow in neuropathology and neurotoxicology at the Johns Hopkins University, MD; and APA Fellow in neuroimaging at the Athinoula Martinos Center of Harvard Medical School. He completed post-graduate training in bioethics at the Neiswanger Institute for Bioethics and Health Policy of Loyola University, IL. Prof. Giordano’s ongoing research addresses the neurobiological bases of moral decision making and neuropsychiatric spectrum disorders; and neuroethical issues arising in and from the development, use, and misuse of neuroscientific techniques and neurotechnologies in medicine, public life, and national security and global relations. In recognition of his ongoing work, he was awarded Germany’s Klaus Reichert Prize in Medicine and Philosophy (with collaborator Dr. Roland Benedikter of the University of California, Santa Barbara).

Hank Greely
Hank Greely

Stanford University
INS Board Member
Hank Greely is the Deane F. and Kate Edelman Johnson Professor of Law and Professor, by courtesy, of Genetics at Stanford University. He specializes in ethical, legal, and social issues arising from advances in the biosciences, particularly from genetics, neuroscience, and human stem cell research. He directs the Stanford Center for Law and the Biosciences and the Stanford Program on Neuroscience in Society; chairs the California Advisory Committee on Human Stem Cell Research; and serves on the Neuroscience Forum of the Institute of Medicine, the Advisory Council for the National Institute for General Medical Sciences of NIH, the Committee on Science, Technology, and Law of the National Academy of Sciences, and the NIH Multi-Council Working Group on the BRAIN Initiative. He was elected a fellow of the American Association for the Advancement of Science in 2007. Professor Greely graduated from Stanford in 1974 and from Yale Law School in 1977. He served as a law clerk for Judge John Minor Wisdom on the United States Court of Appeals and for Justice Potter Stewart of the United States Supreme Court. After working during the Carter Administration in the Departments of Defense and Energy, he entered private practice in Los Angeles in 1981 as a litigator with the law firm of Tuttle & Taylor, Inc. He began teaching at Stanford in 1985. 


Thursday, October 15

Northwestern University Hughes Auditorium
303 E Superior Street, Chicago, IL

To attend this free, public event, please RSVP before October 12. Thank you!

RSVP

Is Professional Football Safe? Could We Make It Safer? Perspectives from Neuroscience, Law, and Ethics

Professional football has come under significant scrutiny in recent years, particularly because of concerns over player health and safety.  While concussions are most often discussed, players also face a variety of other health risks, from joint and muscle problems to cardiac malfunction to issues with chronic pain. But health risks are just one part of story. So, too, are the potential short and long-term benefits these exceptional athletes may reap from the game.

Come learn more about the debate, and about The Football Players Health Study at Harvard University, which seeks to understand and improve the health and wellbeing of former NFL players. This study looks at the risks and benefits of playing football at the professional level over the life of the player, supports novel discoveries and new therapies, and seeks to improve the systems and organizational structures that may affect player health.

Nita Farahany
Nita Farahany

Duke University
INS Board Member

Nita Farahany, JD, PhD, Professor of Law and Professor of Philosophy at Duke, Director of Duke Science and Society, and a member of the Presidential Commission for the Study of Bioethical Issues, will moderate. Professor Farahany serves as a member of the Law and Ethics Advisory Panel for the Football Players Health Study.

Alvaro Pascual-Leone
Alvaro Pascual-Leone

Harvard Medical School
Alvaro Pascual-Leone, MD, PhD, is Professor of Neurology, Associate Dean for Clinical and Translational Research at Harvard Medical School, and Director of the Berenson-Allen Center for Noninvasive Brain Stimulation. Dr. Pascual-Leone serves as Associate Director of the Football Players Health Study at Harvard University. He will explain the study and why the issues facing football players are broader than concussion alone, explore the lack of adequate scientific data on the risks and benefits of playing professional football, and describe what we do know about players' physical and mental health over their entire lives.

I. Glenn Cohen
I. Glenn Cohen

Harvard Law School
I. Glenn Cohen, JD, is Professor of Law at Harvard Law School, and Faculty Director of the Petrie-Flom Center for Health Law Policy, Biotechnology & Bioethics. Professor Cohen serves as the Co-Lead of the Law and Ethics Initiative of the Football Players Health Study at Harvard University. He will discuss the need to comprehensively analyze the non-clinical structural and organizational environment that influences player health.

Damien Richardson
Damien Richardson

Banner University Medical Center
Dr. Damien Richardson is a former NFL player who spent his entire 7-year career as a professional athlete with the Carolina Panthers in Charlotte, North Carolina. He is now a physician and orthopaedic surgery resident at Banner University Medical Center in Phoenix, Arizona. He holds a Medical Degree from the University of California San Francisco, School of Medicine, a Master of Public Health Degree in Quantitative Methods from the Harvard School of Public Health, and a Bachelor of Science degree in bio-engineering from Arizona State University, Tempe, Arizona, where he played collegiate football from 1994-1998. His research interests involve population health sciences focusing on clinical effectiveness and valued based metrics in healthcare. He has been published in multiple peer reviewed journals. Dr. Richardson is a volunteer for numerous organizations as a mentor, speaker, fund raiser, and health educator.